Modella AI Announces Agreement to Accelerate AI-Driven Oncology Clinical Development Read More » July 6, 2025
Johnson & Johnson Seeks EMA Approval to Extend AKEEGA Use for Prostate Cancer Read More » July 3, 2025
Natera to Present Clinical and Economic Utility of Signatera at ESMO GI, Highlights Innovations in MRD Read More » July 2, 2025
Redhill Biopharma Starts Recruitment For Phase 2 Opaganib/darolutamide Combo Study In Advanced Prostate Cancer Read More » July 2, 2025
